COVID-19

COVID-19 in 2025  

The unprecedented COVID-19 pandemic spanning over three years claimed millions of lives worldwide and caused immense misery to the humanity. Rapid developments of vaccines...

CoViNet: A New Network of Global Laboratories for Coronaviruses 

A new global network of laboratories for coronaviruses, CoViNet, has been launched by WHO. The aim behind this initiative is to bring together surveillance...

COVID-19: Severe lung infection affects heart through “cardiac macrophage shift” 

It is known that COVID-19 increases the risk of heart attack, stroke, and Long COVID but what was not known is whether the damage...

JN.1 sub-variant: The Additional Public Health Risk Is Low at the Global Level

JN.1 sub-variant whose earliest documented sample was reported on 25 August 2023 and which was later reported by the researchers to have higher transmissibility and immune...

COVID-19: JN.1 sub-variant has higher transmissibility and immune escape ability 

Spike mutation (S: L455S) is hallmark mutation of JN.1 sub-variant which significantly enhances its immune evasion capability enabling it to effectively evade Class 1...

COVID-19 Not Over Yet: What We Know of the Latest Surge in China 

It is perplexing why China chose to lift zero-COVID policy and do away with the strict NPIs, in winter, just before the Chinese New...

Spikevax Bivalent Original/Omicron Booster Vaccine: First Bivalent COVID-19 Vaccine receives MHRA approval  

Spikevax Bivalent Original/Omicron Booster Vaccine, the first bivalent COVID-19 booster vaccine developed by Moderna has received MHRA approval. Unlike the Spikevax Original, the bivalent version...

Airborne Transmission of Coronavirus: Acidity of aerosols controls infectivity 

Coronaviruses and influenza viruses are sensitive to acidity of aerosol. pH-mediated rapid inactivation of coronaviruses is possible by enriching the indoor air with non-hazardous...

Deltamicron : Delta-Omicron recombinant with hybrid genomes  

Cases of co-infections with two variants were earlier reported. Not much was known about viral recombination yielding viruses with hybrid genomes. Two recent studies report...

Molnupiravir becomes the first Oral Antiviral Drug to be included in WHO’s living Guidelines on COVID-19 Therapeutics 

WHO has updated its living guidelines on COVID-19 therapeutics. The ninth update released on 03 March 2022 include a conditional recommendation on molnupiravir.  Molnupiravir has...

Omicron BA.2 Subvariant is More Transmissible

Omicron BA.2 subvariant seems to be more transmissible than BA.1. It also possesses immune-evasive properties that further reduce the protective effect of vaccination against...

Stay in touch:

92,143FansLike
45,781FollowersFollow
1,772FollowersFollow

Newsletter

Don't miss

Interferon-β for Treatment of COVID-19: Subcutaneous Administration more Effective

Results from the phase2 trial support the view that...

COVID‑19: National Lockdown in the UK

To protect the NHS and save lives., National Lockdown...

A Novel Approach to ‘Repurpose’ Existing Drugs For COVID-19

A combination of biological and computational approach to study...

Did the SARS CoV-2 Virus Originate in Laboratory?

There is no clarity on the natural origin of...

‘Bradykinin Hypothesis’ Explains the Exaggerated Inflammatory Response in COVID-19

A novel mechanism to explain the different unrelated symptoms...